Czech J. Food Sci., 2019, 37(5):345-350 | DOI: 10.17221/114/2018-CJFS

The gluten content in oat products available on the Czech marketFood Analysis, Food Quality and Nutrition

Jana Rysová*, Eva Ma¹ková, Zuzana ©mídová
Department of Research, Food Research Institute Prague, Czech Republic

The gluten content in oat products on the market in the Czech Republic was monitored. The ELISA kit Ridascreen gliadin from R-Biopharm based on the R5 antibody was used for the gliadin determination. Oat products (41 samples), including 21 samples of oat flakes, were tested. Only 6 samples were labelled as gluten-free and it was confirmed that these samples meet the criteria for gluten-free foods. The total of 29 oat products, of which 15 were samples of oat flakes, contained more than 20 mg/kg of gluten. This means that 71% of oat cereal products were contaminated with cereals toxic for people with celiac disease. It was shown that most oat products on the Czech market are not safe for people with gluten intolerance.

Keywords: Keywords: ELISA; gluten; oat products

Published: October 31, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rysová J, Ma¹ková E, ©mídová Z. The gluten content in oat products available on the Czech market. Czech J. Food Sci. 2019;37(5):345-350. doi: 10.17221/114/2018-CJFS.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aaltonen K., Laurikka P., Huhtala H., Maki M., Kaukinen K., Kurppa K. (2017): The long-term consumption of oats in celiac disease patients is safe: A large cross-sectional study. Nutrients, 9: 611. doi: 10.3390/nu9060611. Go to original source... Go to PubMed...
    2. Comino I., de Lourdes Moreno M., Sousa C. (2015): Role of oats in celiac disease. World Journal of Gastroenterology, 21: 11825-11831. Go to original source... Go to PubMed...
    3. Comino I., Bernardo D., Bancel E., de Lourdes-Moreno M., Sanchez B., Barro F., Suligoj T., Ciclitira P.J., Cebolla A., Knight S.C., Branlard G., Sousa C. (2016): Identification and molecular characterization of oat peptides implicated on coeliac immune response. Food & Nutrition Research, 60: 30324. doi: 10.3402/fnr.v60.30324 Go to original source... Go to PubMed...
    4. Cooper S.E.J., Kennedy N.P., Mohamed B.M., Abuzakouk M., Dunne J., Byrne G., McDonald G., Davies A., Edwards C., Kelly J., Feighery C.F. (2013): Immunological indicators of coeliac disease activity are not altered by long-term oats challenge. Clinical & Experimental Immunology, 171: 313-318. Go to original source... Go to PubMed...
    5. Daou S., Zhang H. (2012): Oat Beta-Glucan: Its role in health promotion and prevention of diseases.
    6. Comprehensive Reviews in Food Science and Food Safety, 11: 355-365.
    7. De Souza M.C.P., Deschenes M.E., Laurencelle S., Roy C.C., Djilali-Saiah I. (2016): Pure oats as part of the Canadian gluten-free diet in celiac disease: The need to revisit the issue. Canadian Journal of Gastroenterology and Hepatology, Article ID 1576360, 8 pages. doi.org/10.1155/2016/1576360. Go to original source... Go to PubMed...
    8. Farage P., Boas G.V., Gandolfi L., Oratesi R., Puppin Zandonadi R. (2014): Is the consumption of oats safe for celiac disease patients? A review of literature. Journal of Food and Nutritional Disorders, 3. doi.org/10.4172/23249323.1000138.
    9. Hernando A., Mujico J.R., Mena M.C., Lombardía M., Méndez E. (2008): Measurement of wheat gluten and barley hordeins in contaminated oats from Europe, the United States and Canada by Sandwich R5 ELISA. European Journal of Gastroenterology and Hepatology, 20: 545-554. Go to original source... Go to PubMed...
    10. Chmelová D., Ondrejoviè M., Havrlentová M., Hozlár P. (2015): Antioxidant activity in naked and hulled oat (Avena sativa l.) varieties. Journal of Microbiology, Biotechnology and Food Sciences, 4: 63-65. Go to original source...
    11. Kahlenberg F., Sanchez D., Lachman I., Tuckova L., Tlaskalova H., Mendez E., Mothes T. (2006): Monoclonal antibody R5 for detection of putatively coeliac-toxic gliadin peptide.
    12. European Food Research and Technology, 222: 78-82.
    13. Kaukinen K., Collin P., Huhtal, H., Mäki M. (2013): Longterm consumption of oats in adult celiac disease patients. Nutrients, 5: 4380-4389. Go to original source... Go to PubMed...
    14. Koenig R., Dickman J. R., Kang Ch., Chu Y. F., Li L. (2014): Avenanthramide supplementation attenuates exerciseinduced inflammation in postmenopausal women. Nutrition Journal, 13: 21. doi: 10.1186/1475-2891-13-21. Go to original source... Go to PubMed...
    15. Lerner A. (2014): The enigma of oats in nutritional therapy for celiac disease. International Journal of Celiac Disease, 2: 110-114. Go to original source...
    16. La Vieille S., Pulido O. M., Abbot M., Koerner T., Godefroy S. (2016): Celiac disease and gluten-free oats: A Canadian position based on a literature review., Article ID 1870305, 10 pages. doi: 10.1155/2016/1870305.https://doi.org/10.17221/114/2018-CJFS Go to original source... Go to PubMed...
    17. Pawlovska P., Diowksz A., Kordialik-Bogacka E. (2012): State-of-the-art incorporation of oat into a gluten-free diet. Food Reviews International, 8: 330-342. Go to original source...
    18. Pinto-Sanchez M. I., Causada-Calo N., Bercik P., Ford, A.C., Murray J.A., Armstrong D., Semrad C., Kupfer, S.S., Alaedini, A., Moayyedi, P., Leffler, D.A., Verdú, E.F., Green, P. (2017): Safety of adding oats to a gluten-free diet for patients with celiac disease: Systematic review and meta-analysis of clinical and observational studies. Gastroenterology, 153: 395-409. Go to original source... Go to PubMed...
    19. Pulido O. M., Gillespie Z., Zarkadas M., Dubois S., Vavasour E., Rashid M., Switze, C., Godefroy S. B. (2009): Introduction of oats in the diet of individuals with celiac disease: a systematic review. Advances in Food and Nutrition Research, 7: 235-285. Go to original source... Go to PubMed...
    20. Real A., Comino I., de Lorenzo l., Merchan F., Gil-Humanes J., Gimenez M., Lopez-Casado M. A., Torres M. I., Cebolla A., Sousa C., Barr, F., Pisto, F. (2012): Molecular and immunological characterization of gluten proteins isolated from oat cultivars that differ in toxicity for celiac disease. Plos ONE, 7: e48365. doi: 10.1371/journal.pone.0048365. Go to original source... Go to PubMed...
    21. Silano M., Pozo E. P., Uberti F., Manferdelli S., Del Pinto T., Felli C., Budelli A., Vincentini O., Restani P. (2014): Diversity of oat varieties in eliciting the early inflammatory events in celiac disease. European Journal of Nutrition, 53: 1177-1186. Go to original source... Go to PubMed...
    22. Singh R., De S., Belkheir A. (2013): Avena sativa (Oat), a potencial nutraceutical and therapeutic agent. An overview. Critical Reviews in Food Science and Nutrition, 53: 126-144. Go to original source... Go to PubMed...
    23. Sjöberg V., Hollen E., Pietz G., Magnusson K. E., Magnusson K. F., Sundström M., Holmgren Peterson K., Sundström O., Hernell O., Hammarström S., Högberg L., Hammarström M. L. (2014): Noncontaminated dietary oats may hamper normalization of the intestinal immune status in childhood celiac disease. Clinical and Translational Gastroenterology, 5: e58. doi: 10.1038/ctg.2014.9. Go to original source... Go to PubMed...
    24. Tapsas D., Fälth-Magnusson K., Högberh L., Hammersjö J. A., Hollén E. (2014): Swedish children with celiac disease comply well with a gluten-free diet, and most include oats without reporting any adverse effects: a long-term follow-up study. Nutrition research, 34: 436-441. Go to original source... Go to PubMed...
    25. Thompson T. (2004): Gluten contamination of commercial oat products in the United States. New England Journal of Medicine, 351: 2021-2022. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content